Risk of Thromboembolism With Eltrombopag: A Case Report of Deep Vein Thrombosis and Bilateral Pulmonary Embolism

被引:3
|
作者
Ghumman, Ghulam Mujtaba [1 ]
Fatima, Huda [1 ]
Singh, Gunbir [1 ]
Khalid, Taha [2 ]
Ayoubi, Mohamed [3 ]
机构
[1] St Vincent Mercy Med Ctr, Internal Med, Toledo, OH 43608 USA
[2] MedStar Union Mem Hosp, Internal Med, Baltimore, MD USA
[3] St Vincent Mercy Med Ctr, Hematol & Oncol, Toledo, OH USA
关键词
chronic itp; thrombosis; platelets; eltrombopag; thrombocytopenia; THROMBOPOIETIN RECEPTOR AGONISTS; PRIMARY IMMUNE THROMBOCYTOPENIA; LONG-TERM; EFFICACY; SAFETY; MANAGEMENT; PURPURA; ITP;
D O I
10.7759/cureus.33615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Eltrombopag is a second-line therapy for refractory thrombocytopenia from immune thrombocytopenic purpura (ITP). The medication is generally well tolerated but can lead to adverse thromboembolic complications in rare instances. We present a case of lower extremity deep vein thrombosis with bilateral pulmonary embolism in an ITP patient receiving eltrombopag. The patient underwent catheter-directed thrombolysis for pulmonary embolism. Eltrombopag was stopped on discharge, considering the potential cause of venous thrombosis.
引用
收藏
页数:4
相关论文
共 50 条